Biofarm | Romania Feed

Biofarm, one of the most important drug producers in Romania, estimates a 16% increase in turnover for this year, after recording a value of 239 million lei and an EBITDA of approximately 2021 in 2021 82 million lei, and for 2022 it aims to increase it by 15% compared to the end of the year. […]

Biofarm, one of the most important drug manufacturers in Romania, reports positive developments for the preliminary results of 2021: turnover of 239 million lei and a net profit of 60 million lei, up 11% compared to 2020. In addition, Biofarm reported EBITDA of 82 million lei, up 10% compared to 2020.    “Innovation, the driving […]

Biofarm, one of the most important drug manufacturers in Romania, inaugurated a new production and testing facility in Bucharest, in which over EUR 35 million were invested and celebrates 100 years of uninterrupted activity.   With a usable area of over 10.000 sqm and an annual production flow three times higher than in the existing plant, […]